While plasma cells represent the end-stage of differentiation in B lymphocytes, a subset of MM patients shared common features with earlier stage B cell malignancies and had TLR and BCR-mediated NF-κB signaling activated by mutation (Fig. 2a, b)25–27. This evidence concerns the gene BCR and Miyoshi myopathy.